InCarda Therapeutics is Drug Discovery in United States that focus on lead treatment leverages business. Founded in 2009. They cover business area such as operator, cardiovascular condition, disease, inhale therapy, medicine, cardiac tissue, drug, affect region, doctor, paroxysmal atrial fibrillation, (PAF, atrial arrhythmia.
2009
( 15 years old in 2024 )
Lead Treatment Leverages
-
39899 Balentine Drive
Suite 185
Newark, CA 94560
United States
Private
operatorcardiovascular conditiondiseaseinhale therapymedicinecardiac tissuedrugaffect regiondoctorparoxysmal atrial fibrillation(PAFatrial arrhythmia
* We use standard office opening hours in near InCarda Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
InCarda Therapeutics is Drug Discovery business from United States that founded in 2009 (15 years old in 2024), InCarda Therapeutics business is focusing on Lead Treatment Leverages.
InCarda Therapeutics headquarter office and corporate office address is located in 39899 Balentine Drive Suite 185 Newark, CA 94560 United States.
InCarda Therapeutics was founded in United States.
In 2024, InCarda Therapeutics is currently focus on lead treatment leverages sector.
Above is snippet of Google Trends for "lead treatment leverages" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with InCarda Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
